Evaluation of Arts-Based Storytelling Program in Adolescents With Diabetes
7 de agosto de 2026 actualizado por: University of California, San Francisco
The goal of this clinical trial is to evaluate whether an arts-based storytelling and narrative medicine workshop series can improve social connection, illness identity, and psychological well-being in adolescents and young adults with chronic illness, specifically diabetes.
The main questions it aims to answer are:
- Does participation in a narrative-based storytelling workshop improve social connectedness and peer support among adolescents and young adults with diabetes?
- Does engagement in creative arts and reflective storytelling support identity formation, self-expression, and emotional well-being in this population?
Participants will be 16-25 years old and recruited through the UCSF Pediatric Diabetes Clinic. Individuals must be able to participate in group workshops and complete surveys and interviews related to the study.
Participants will:
- Attend eight weekly workshops centered on storytelling, reflection, and creative expression
- Engage in narrative medicine activities, including writing, storytelling, drawing, and facilitated reflection
- Participate in group discussions focused on personal experiences with chronic illness
- Complete pre- and post-intervention surveys assessing psychosocial outcomes such as social connectedness, illness identity, self-concept, and mental well-being
- Participate in interviews and reflective exercises about their experiences in the program
This study aims to explore the role of narrative medicine and arts-based interventions in supporting adolescents and young adults with chronic illness and assess their potential benefits as a supplement to standard medical care.
Descripción general del estudio
Estado
Activo, no reclutando
Condiciones
Intervención / Tratamiento
Tipo de estudio
Intervencionista
Inscripción (Estimado)
10
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
California
-
San Francisco, California, Estados Unidos, 94107
- University of California, San Francisco
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Niño
- Adulto
Acepta Voluntarios Saludables
No
Descripción
Inclusion Criteria:
- Participants must be patients at the UCSF Pediatric Diabetes Clinic
- Participants must have a self-reported diagnosis of diabetes
- Participants must be between 16-25 years old
- The participant and/or caregiver(s) must be English-speaking
Exclusion Criteria:
- Participants unable to attend the first session
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Cuidados de apoyo
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Arts-Based Storytelling Workshop Series
Participants in this study will take part in an eight-week arts-based storytelling workshop series designed to promote social connection, self-expression, illness identity development, and psychological well-being in adolescents and young adults with diabetes.
Workshops will be conducted weekly and will include: -Close engagement with written, visual, or artistic materials centered on themes such as identity, resilience, relationships, uncertainty, growth, and coping with chronic disease - Facilitated group discussions and sharing intended to foster peer support, connection, emotional processing, and self-expression - Creative arts exercises, including writing, storytelling, drawing, or other forms of creative expression in response to structured prompts
|
The Arts-Based Storytelling Workshop Series is a structured eight-week behavioral intervention designed to enhance self-expression, social connection, emotional reflection, and psychological well-being in adolescents and young adults with diabetes.
This intervention differs from traditional educational or counseling approaches by integrating creative expression, guided reflection, and group dialogue as therapeutic tools.
Each weekly session includes: -Engagement with written, visual, or artistic prompts centered on themes such as identity, resilience, relationships, coping, uncertainty, and growth in the context of chronic illness -Facilitated group discussion and sharing designed to promote peer support, emotional processing, and a sense of community among participants - Creative exercises in response to structured prompts, including writing, storytelling, drawing, or other expressive activities that support personal reflection
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Participant retention and attendance
Periodo de tiempo: Throughout intervention (Weeks 1-8), assessed immediately post-intervention (Week 8)
|
Feasibility will be assessed by tracking the number of participants who attend each of the 8 weekly sessions, including overall completion of the program.
|
Throughout intervention (Weeks 1-8), assessed immediately post-intervention (Week 8)
|
|
Participant satisfaction
Periodo de tiempo: Immediately post-intervention (Week 8)
|
Acceptability will be assessed using post-intervention satisfaction questionnaires with 5-point Likert-scale items and semi-structured individual interviews.
Measures will evaluate perceived relevance of workshop content, usefulness of creative prompts, quality of group discussion, and facilitation experience.
Scale title: Intervention Satisfaction Questionnaire (ISQ) Minimum value: 1 (Strongly Disagree) Maximum value: 5 (Strongly Agree) Interpretation: Higher scores indicate greater satisfaction with the intervention.
|
Immediately post-intervention (Week 8)
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Illness identity
Periodo de tiempo: Pre-intervention (Week 0) and post-intervention (Week 8)
|
Assessed using the Illness Identity Questionnaire, which evaluates how individuals integrate a chronic illness into their sense of self.
Scores reflect different illness identity orientations, with higher scores indicating stronger endorsement of the corresponding identity state.
Scale title: Illness Identity Questionnaire (IIQ) Minimum value: 1 (Strongly Disagree) Maximum value: 5 (Strongly Agree) Interpretation: Subscale scores reflect distinct illness identity states; higher scores indicate greater endorsement of that identity orientation
|
Pre-intervention (Week 0) and post-intervention (Week 8)
|
|
Social connectedness
Periodo de tiempo: Pre-intervention (Week 0) and post-intervention (Week 8)
|
Measured using the Social Connectedness Scale (SCS), which assesses perceived closeness to others and sense of belonging.
Scale title: Social Connectedness Scale (SCS) Minimum value: 1 (Strongly Disagree) Maximum value: 6 (Strongly Agree) Interpretation: Higher scores indicate greater feelings of social connectedness and belonging.
|
Pre-intervention (Week 0) and post-intervention (Week 8)
|
|
Self-reported well-being
Periodo de tiempo: Pre-intervention (Week 0) and post-intervention (Week 8)
|
Measured using the WHO-5 is a self-report instrument measuring mental well-being.
Scale title: Psychosocial functioning scale (PFQ) Minimum value: 0 (At no time) Maximum value: 5 (All of the time) Interpretation: Higher scores indicate greater well-being.
|
Pre-intervention (Week 0) and post-intervention (Week 8)
|
|
Self-esteem
Periodo de tiempo: Pre-intervention (Week 0) and post-intervention (Week 8)
|
Measured using the Rosenberg Self-Esteem Scale (RSE), which assesses global self-worth, self-worth and self-acceptance.
Scale Minimum value: 1 (Strongly agree) Maximum value: 4 (Strongly disagree) Interpretation: Higher total scores indicating more positive self-esteem.
|
Pre-intervention (Week 0) and post-intervention (Week 8)
|
|
Qualitative themes from interviews and group reflections
Periodo de tiempo: Pre-intervention (Week 0) and post-intervention (Week 8)
|
Semi-structured interviews will explore participant experiences of identity development, meaning-making, peer support, and emotional processing.
Transcripts will be analyzed using thematic analysis to identify recurring patterns and narrative themes related to chronic illness experience and psychosocial adaptation.
|
Pre-intervention (Week 0) and post-intervention (Week 8)
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Investigadores
- Investigador principal: Anoushka Sinha, MD, MS, University of California, San Francisco
- Silla de estudio: Lina Lew, BS, University of California, San Francisco
- Silla de estudio: Calis Lim, BS, Rosalind Franklin University
Publicaciones y enlaces útiles
La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.
Publicaciones Generales
- Gucciardi E, Jean-Pierre N, Karam G, Sidani S. Designing and delivering facilitated storytelling interventions for chronic disease self-management: a scoping review. BMC Health Serv Res. 2016 Jul 11;16:249. doi: 10.1186/s12913-016-1474-7.
- Yuan Y, Zhou S, Xu J, Li X. Promoting Resilience and Well-Being of Young Adults with Diabetes Through Digital Storytelling in Arts-Based Research. Health Commun. 2025 Nov;40(13):2828-2838. doi: 10.1080/10410236.2024.2424408. Epub 2024 Nov 6.
- Wigham S, Watts P, Zubala A, Jandial S, Bourne J, Hackett S. Using Arts-Based Therapies to Improve Mental Health for Children and Young People With Physical Health Long-Term Conditions: A Systematic Review of Effectiveness. Front Psychol. 2020 Sep 25;11:1771. doi: 10.3389/fpsyg.2020.01771. eCollection 2020.
- Maragh-Bass AC, Dinh N, Cooney G, Aikhuele E, Chandler R, Hughes R, Jones Z, Thomas S, Soberano ZR, Stocks JB, Budhwani H, Hightow-Weidman LB, Lorenzetti L. The role of digital storytelling methods in promoting health-related outcomes among young adults of color: a systematic review. Mhealth. 2025 Jul 14;11:42. doi: 10.21037/mhealth-24-65. eCollection 2025.
- Lanis A, Tu E, Peskin M, Melendez M, Tarshish G, Akinsete A, Hoffman A, Kenney-Riley K, Rubinstein T, Wahezi D. Storytelling of Young Adults with Chronic Rheumatologic Illnesses: A Pilot Study. Healthcare (Basel). 2022 Oct 9;10(10):1979. doi: 10.3390/healthcare10101979.
- Gucciardi E, Reynolds E, Karam G, Beanlands H, Sidani S, Espin S. Group-based storytelling in disease self-management among people with diabetes. Chronic Illn. 2021 Sep;17(3):306-320. doi: 10.1177/1742395319859395. Epub 2019 Jul 2.
- Continisio GI, Nunziata F, Coppola C, Bruzzese D, Spagnuolo MI, Guarino A. Enhancing the care of children with chronic diseases through the narratives of patient, physician, nurse and carer. Scand J Psychol. 2021 Feb;62(1):58-63. doi: 10.1111/sjop.12690. Epub 2020 Nov 18.
- Rappolt EL, Cho E, Tanenbaum ML, Myers A, Mulvaney SA. Story-based interventions for chronic health conditions in youth: a systematic review and narrative synthesis. J Pediatr Psychol. 2026 Jul 1;51(7):579-592. doi: 10.1093/jpepsy/jsag014.
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Actual)
13 de julio de 2026
Finalización primaria (Estimado)
1 de septiembre de 2026
Finalización del estudio (Estimado)
1 de septiembre de 2026
Fechas de registro del estudio
Enviado por primera vez
29 de mayo de 2026
Primero enviado que cumplió con los criterios de control de calidad
29 de mayo de 2026
Publicado por primera vez (Actual)
4 de junio de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
11 de agosto de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
7 de agosto de 2026
Última verificación
1 de agosto de 2026
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 26-46489
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
NO
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .